Healthcare provider profile · identity verified

Christopher Ryan Hagenson, DO

Family Practice · CLINTON, TN · NPI 1083062517

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	455	140
Lisinopril	Lisinopril	354	104
Gabapentin	Gabapentin	328	59
Amlodipine Besylate	Amlodipine Besylate	274	82
Losartan Potassium	Losartan Potassium	274	80
Levothyroxine Sodium	Levothyroxine Sodium	258	76
Omeprazole	Omeprazole	253	79
Metformin Hcl	Metformin Hcl	247	76
Pantoprazole Sodium	Pantoprazole Sodium	241	79
Simvastatin	Simvastatin	239	68
Hydrochlorothiazide	Hydrochlorothiazide	165	49
Trazodone Hcl	Trazodone Hcl	164	50
Ozempic	Semaglutide	150	24
Rosuvastatin Calcium	Rosuvastatin Calcium	144	42
Meloxicam	Meloxicam	138	60
Metoprolol Tartrate	Metoprolol Tartrate	134	42
Metoprolol Succinate	Metoprolol Succinate	124	35
Tramadol Hcl	Tramadol Hcl	119	27
Pregabalin	Pregabalin	114	17
Escitalopram Oxalate	Escitalopram Oxalate	108	27
Tamsulosin Hcl	Tamsulosin Hcl	103	35
Fluticasone Propionate	Fluticasone Propionate	102	37
Sertraline Hcl	Sertraline Hcl	101	30
Metformin Hcl Er	Metformin Hcl	100	30
Citalopram Hbr	Citalopram Hydrobromide	99	29
Eliquis	Apixaban	96	28
Albuterol Sulfate Hfa	Albuterol Sulfate	95	40
Glimepiride	Glimepiride	95	28
Duloxetine Hcl	Duloxetine Hcl	94	23
Famotidine	Famotidine	93	38
Prednisone	Prednisone	83	57
Jardiance	Empagliflozin	79	15
Furosemide	Furosemide	77	37
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	73	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	71	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	71	19
Mounjaro	Tirzepatide	69	13
Pravastatin Sodium	Pravastatin Sodium	67	20
Donepezil Hcl	Donepezil Hcl	60	15
Carvedilol	Carvedilol	59	22
Spironolactone	Spironolactone	59	20
Clopidogrel	Clopidogrel Bisulfate	58	17
Tizanidine Hcl	Tizanidine Hcl	57	24
Benazepril Hcl	Benazepril Hcl	56	14
Hydralazine Hcl	Hydralazine Hcl	56	19
Allopurinol	Allopurinol	55	17
Celecoxib	Celecoxib	55	21
Ondansetron Hcl	Ondansetron Hcl	55	25
Naproxen	Naproxen	54	30
Januvia	Sitagliptin Phosphate	53	11
Mirtazapine	Mirtazapine	53	16
Buspirone Hcl	Buspirone Hcl	52	21
Potassium Chloride	Potassium Chloride	52	19
Triamcinolone Acetonide	Triamcinolone Acetonide	52	29
Quetiapine Fumarate	Quetiapine Fumarate	51	18
Xarelto	Rivaroxaban	51	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	49	14
Montelukast Sodium	Montelukast Sodium	48	16
Symbicort	Budesonide/Formoterol Fumarate	48	11
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	47	24
Bupropion Xl	Bupropion Hcl	46	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	suppressed
Lorazepam	Lorazepam	46	13
Fluoxetine Hcl	Fluoxetine Hcl	45	18
Valsartan	Valsartan	45	12
Esomeprazole Magnesium	Esomeprazole Magnesium	42	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	41	22
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	41	12
Pioglitazone Hcl	Pioglitazone Hcl	39	11
Venlafaxine Hcl Er	Venlafaxine Hcl	38	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	37	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	35	suppressed
Alendronate Sodium	Alendronate Sodium	34	13
Baclofen	Baclofen	32	suppressed
Cephalexin	Cephalexin	32	27
Atenolol	Atenolol	31	suppressed
Synthroid	Levothyroxine Sodium	31	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	25
Clonazepam	Clonazepam	30	suppressed
Methocarbamol	Methocarbamol	30	15
Clonidine Hcl	Clonidine Hcl	29	suppressed
Lovastatin	Lovastatin	29	suppressed
Azithromycin	Azithromycin	28	27
Ibuprofen	Ibuprofen	28	suppressed
Ramipril	Ramipril	28	suppressed
Rybelsus	Semaglutide	28	suppressed
Fenofibrate	Fenofibrate	26	suppressed
Promethazine Hcl	Promethazine Hcl	26	suppressed
Cefdinir	Cefdinir	25	22
Fluconazole	Fluconazole	25	16
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	24
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Ezetimibe	Ezetimibe	24	suppressed
Meclizine Hcl	Meclizine Hcl	24	18
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Premarin	Estrogens, Conjugated	22	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Ondansetron Odt	Ondansetron	21	17
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Nebivolol Hcl	Nebivolol Hcl	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Bumetanide	Bumetanide	19	suppressed
Bupropion Hcl	Bupropion Hcl	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	17
Nitroglycerin	Nitroglycerin	19	14
Olmesartan Medoxomil	Olmesartan Medoxomil	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	16	suppressed
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	12
Finasteride	Finasteride	15	suppressed
Glyxambi	Empagliflozin/Linagliptin	15	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	14	13
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Cholestyramine	Cholestyramine (With Sugar)	13	suppressed
Colchicine	Colchicine	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Estradiol	Estradiol	12	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Levofloxacin	Levofloxacin	12	suppressed
Lunesta	Eszopiclone	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error